Creative Medical Technology Holdings, Inc. Increase (Decrease) in Interest Payable, Net
Creative Medical Technology Holdings, Inc. (CELZ) reported Increase (Decrease) in Interest Payable, Net of $2.62 thousand for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2016-05-13
- Creative Medical Technology Holdings, Inc. increase (decrease) in interest payable, net for the quarter ending 2016-03-31 was $2.62K, a 65.38% increase year-over-year.
- Creative Medical Technology Holdings, Inc. increase (decrease) in interest payable, net for the quarter ending 2015-12-31 was $2.58K, a 12.07% increase year-over-year.
- Creative Medical Technology Holdings, Inc. increase (decrease) in interest payable, net for the quarter ending 2015-09-30 was $2.57K, a 16.68% increase year-over-year.
- Creative Medical Technology Holdings, Inc. increase (decrease) in interest payable, net for the quarter ending 2015-06-30 was $2.50K, a 18.76% increase year-over-year.
- Creative Medical Technology Holdings, Inc. increase (decrease) in interest payable, net for fiscal 2015 was $9.23K, a 7.54% increase from fiscal 2014.
- Creative Medical Technology Holdings, Inc. increase (decrease) in interest payable, net for fiscal 2014 was $8.59K, a 56.54% increase from fiscal 2013.
- Creative Medical Technology Holdings, Inc. increase (decrease) in interest payable, net for fiscal 2013 was $5.49K, a 0.07% decline from fiscal 2012.
- Creative Medical Technology Holdings, Inc. increase (decrease) in interest payable, net for fiscal 2012 was $5.49K.
| Period end | Increase (Decrease) in Interest Payable, Net 3 month | Increase (Decrease) in Interest Payable, Net 6 month | Increase (Decrease) in Interest Payable, Net 9 month | Increase (Decrease) in Interest Payable, Net 12 month |
|---|---|---|---|---|
| 2016-03-31 | $2.62K 10-Q · filed 2016-05-13 | $5.20K derived: sum of 2 quarters · filed 2016-05-13 | $7.77K derived: sum of 3 quarters · filed 2016-05-13 | $10.27K derived: sum of 4 quarters · filed 2016-05-13 |
| 2015-12-31 | $2.58K derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-14 | $5.15K derived: sum of 2 quarters · filed 2016-04-14 | $7.65K derived: sum of 3 quarters · filed 2016-04-14 | $9.23K 10-K · filed 2016-04-14 |
| 2015-09-30 | $2.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $5.07K derived: sum of 2 quarters · filed 2015-11-09 | $6.65K 10-Q · filed 2015-11-09 | $8.96K derived: sum of 4 quarters · filed 2016-05-13 |
| 2015-06-30 | $2.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $4.08K 10-Q · filed 2015-08-13 | $6.39K derived: sum of 3 quarters · filed 2016-05-13 | $8.59K derived: sum of 4 quarters · filed 2016-05-13 |
| 2015-03-31 | $1.58K 10-Q · filed 2016-05-13 | $3.89K derived: sum of 2 quarters · filed 2016-05-13 | $6.09K derived: sum of 3 quarters · filed 2016-05-13 | $8.19K derived: sum of 4 quarters · filed 2016-05-13 |
| 2014-12-31 | $2.30K derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-14 | $4.50K derived: sum of 2 quarters · filed 2016-04-14 | $6.61K derived: sum of 3 quarters · filed 2016-04-14 | $8.59K 10-K · filed 2016-04-14 |
| 2014-09-30 | $2.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $4.31K derived: sum of 2 quarters · filed 2015-11-09 | $6.28K 10-Q · filed 2015-11-09 | $8.05K derived: sum of 4 quarters · filed 2015-11-09 |
| 2014-06-30 | $2.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $4.08K 10-Q · filed 2015-08-13 | $5.85K derived: sum of 3 quarters · filed 2015-08-13 | $6.22K derived: sum of 4 quarters · filed 2015-08-13 |
| 2014-03-31 | $1.98K 10-Q · filed 2015-05-08 | $3.74K derived: sum of 2 quarters · filed 2015-05-08 | $4.11K derived: sum of 3 quarters · filed 2015-05-08 | $5.87K derived: sum of 4 quarters · filed 2015-05-08 |
| 2013-12-31 | $1.77K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $2.14K derived: sum of 2 quarters · filed 2015-02-27 | $3.89K derived: sum of 3 quarters · filed 2015-02-27 | $5.49K 10-K · filed 2015-02-27 |
| 2013-09-30 | $369.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $2.12K derived: sum of 2 quarters · filed 2014-11-12 | $3.72K 10-Q · filed 2014-11-12 | $5.20K derived: sum of 4 quarters · filed 2014-11-12 |
| 2013-06-30 | $1.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $3.35K 10-Q · filed 2014-08-08 | $4.83K derived: sum of 3 quarters · filed 2014-08-08 | $6.25K derived: sum of 4 quarters · filed 2014-08-08 |
| 2013-03-31 | $1.59K 10-Q · filed 2014-05-13 | $3.08K derived: sum of 2 quarters · filed 2014-05-13 | $4.50K derived: sum of 3 quarters · filed 2014-05-13 | $5.84K derived: sum of 4 quarters · filed 2014-05-13 |
| 2012-12-31 | $1.49K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $2.90K derived: sum of 2 quarters · filed 2014-03-17 | $4.25K derived: sum of 3 quarters · filed 2014-03-17 | $5.49K 10-K · filed 2014-03-17 |
| 2012-12-03 | $5.49K 10-K · filed 2013-03-15 | |||
| 2012-09-30 | $1.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $2.76K derived: sum of 2 quarters · filed 2013-11-13 | $4.00K 10-Q · filed 2013-11-13 | $8.19K derived: sum of 4 quarters · filed 2013-11-13 |
| 2012-06-30 | $1.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $2.58K 10-Q · filed 2013-08-07 | $6.77K derived: sum of 3 quarters · filed 2013-08-07 | |
| 2012-03-31 | $1.24K 10-Q · filed 2013-05-07 | $5.42K derived: sum of 2 quarters · filed 2013-05-07 | ||
| 2011-12-31 | $4.18K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $4.22K 10-K · filed 2013-03-15 | ||
| 2011-09-30 | $42.00 10-Q · filed 2011-10-31 | |||
| 2010-09-30 | $0.00 10-Q · filed 2011-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |